Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Serbia to Start Sale of Galenika Drugmaker in Early 2013

Don't Miss Out —
Follow us on:

Dec. 13 (Bloomberg) -- Serbia plans to start the sale of its drugmaker Galenika AD in early 2013, the government said in an e-mailed statement today.

The state may offer a stake in the Zemun, Serbia-based company to the European Bank for Reconstruction and Development, General Manager Zivomir Novakovic said on Oct. 30.

The company posted a loss of 122 million euros ($160 million) in 2011.

To contact the reporter on this story: Misha Savic in Belgrade at msavic2@bloomberg.net

To contact the editor responsible for this story: James M. Gomez at jagomez@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.